Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: A feasibility study on three cases with pathological and immunohistochemical evaluation

Thyroid

Volumn 23, Issue 12, 2013, Pages 1578-1582

  Valcavi, Roberto ^a   Piana, Simonetta ^a   Bortolan, Giorgio Stecconi ^a   Lai, Roberta ^a   Barbieri, Verter ^a   Negro, Roberto ^b  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b VITO FAZZI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BRAF V600E; MITOCHONDRION ANTIBODY; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PATIENT; CASE REPORT; CELL SHAPE; CHIBA NEEDLE; CHROMATIN; CLINICAL FEATURE; DISTANT METASTASIS; DNA SEQUENCE; ECHOGRAPHY; FATALITY; FEASIBILITY STUDY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; GENE MUTATION; GENERAL ANESTHESIA; HIGH RISK PATIENT; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LASER SURGERY; LYMPH NODE METASTASIS; MICROMETASTASIS; OPERATING ROOM; OPTIC NERVE FIBER; PAPILLARY THYROID MICROCARCINOMA; PRIORITY JOURNAL; PSAMMOMA BODY; RECURRENT LARYNGEAL NERVE; SUBTOTAL THYROIDECTOMY; THERMAL INJURY; THYROID CARCINOMA; THYROIDECTOMY; TUMOR INVASION; TUMOR VOLUME;

ADULT; CARCINOMA, PAPILLARY; FEASIBILITY STUDIES; FEMALE; HUMANS; LASER THERAPY; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; THYROID NEOPLASMS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84890321852     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0279     Document Type: Article

References (22)

1. Pacella CM, Bizzarri G, Spiezia S, Bianchini A, Guglielmi R, Crescenzi A, Pacella S, Toscano V, Papini E 2004 Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology 232: 272-280. (Pubitemid 38787849)
2. Valcavi R, Riganti F, Bertani A, Formisano D, Pacella CM 2010 Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients. Thyroid 20: 1253-1261.
3. Døssing H, Bennedbæk FN, Hegedüs L 2011 Long-term outcome following interstitial laser photocoagulation of benign cold thyroid nodules. Eur J Endocrinol 165: 123-128.
4. Monchik JM, Donatini G, Iannuccilli J, Dupuy DE 2006 Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg 244: 296-304. (Pubitemid 44305546)
5. Papini E, Bizzarri G, Bianchini A, Valle D, Misischi I, Guglielmi R, Salvatori M, Solbiati L, Crescenzi A, Pacella CM, Gharib H 2013 Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer. J Clin Endocrinol Metab 98: E92-E97.
6. Papini E, Guglielmi R, Gharib H, Misischi I, Chianelli M, Crescenzi A, Bianchini A, Valle D, Bizzarri G 2011 Ultrasound- guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk. Thyroid 21: 917-920.
7. Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK, Frable W 2008 Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. J Diagn Cytopathol 36: 425-437. (Pubitemid 351829800)
8. Sancisi V, Nicoli D, Ragazzi M, Piana S, Ciarrocchi A 2012 BRAFV600E mutation does not mean distant metastasis in thyroid papillary carcinomas. J Clin Endocrinol Metab 97: 1745-1749.
9. Piana S, Riganti F, Froio E, Andrioli M, Pacella CM, Valcavi R 2012 Pathological findings of thyroid nodules after percutaneous laser ablation: a series of 22 cases with cytohistological correlation. Endocr Pathol 23: 94-100.
10. Edge SB, Byrd DR, Compton CC, Fritz AG, Frederick LG, Trotti A (eds) 2010 Thyroid. In: AJCC Cancer Staging Manual. Seventh edition. Springer, New York, pp 87-96.
11. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 19:1167-1214.
12. Erratum in: Thyroid 2010 20: 674-675.
13. Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, Higashiyama T, Tomoda C, Takamura Y, Kobayashi K, Miya A 2010 An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34: 28-35.
14. Motoyoshi A, Noguchi M, Earashi M, Zen Y, Fujii H 2010 Histopathological and immunohistochemical evaluations of breast cancer treated with radiofrequency ablation. J Surg Oncol 102: 385-391.
15. Schneider T, Warth A, Herpel E, Schnabel PA, von Deimling A, Eberhardt R, Herth FJ, Dienemann H, Hoffmann H 2009 Intraoperative radiofrequency ablation of lung metastases and histologic evaluation. Ann Thorac Surg 87: 379-384.
16. Itoh T, Orba Y, Takei H 2002 Immunohistochemical detection of hepatocellular carcinoma in the setting of ongoing necrosis after radiofrequency ablation. Mod Pathol 15: 110-115. (Pubitemid 34171320)
17. Jaskolka JD, Kachura JR, Hwang DM 2010 Pathologic assessment of radiofrequency ablation of pulmonary metastases. J Vasc Interv Radiol 21: 1689-1696.
18. Burak WE, Agnese AM, Povoski SP 2003 Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision. Cancer 98: 1369-1376. (Pubitemid 37151490)
19. Ordóñez NG 2012 Value of thyroid transcriptor factor-1 immunostaining in tumor diagnosis: a review and update. Appl Immunohistochem Mol Morphol 20: 429-444.
20. Weiss LM, Gaffey MJ, Warhol MJ, Mehta P, Bonsib SM, Bruder E, Santos E, Mederios LJ 1991 Immunocytochemical characterization of a monoclonal antibody directed against mitochondria reactive in paraffin-embedded sections. Mod Pathol 4: 596-601.
21. Nikiforov YE, Nikiforova MN 2011 Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol 7: 569-580.
22. Kim TH, Park YJ, Lim JA, Ahn HY, Lee EK, Lee YJ, Kim KW, Hahn SK, Youn YK, Kim KH, Cho BY, Park do J 2012 The association of the BRAF (V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis. J Cancer 118: 1764-1773.